CHEN Wei
chief physician
mailbox: [email protected]
Tel: 13601895142
Research Fields: Pathogenesis and Chemotherapy Resistance of Biliary Tract Tumor
Biography
Doctor, master's supervisor, chief physician, deputy director of biliary and pancreatic surgery of Renji Hospital affiliated to Shanghai Jiaotong University School of Medcine. At present, he is a member of the professional committee of biliary surgery of the Chinese Medical Association, a member of the professional committee of biliary tract tumor of the Chinese branch of the international hepatobiliary pancreatic Association, a member of the professional committee of biliary calculus of the Chinese branch of the international hepatobiliary pancreatic Association, a member of the hepatobiliary pancreatic oncology group of the Chinese Research Hospital Association, a deputy head of the biliary group of the surgical branch of the Shanghai Medical Association, and a member of the multi regional diagnosis and treatment cooperation group of the pancreatic cancer Professional Committee of the Shanghai anti cancer association. Clinically, he has been engaged in the clinical and basic research of biliary and pancreatic diseases for a long time, and participated in the compilation of Expert Consensus on Technical Specifications for the Treatment of Esophagogastric Varices Bleeding in Portal Hypertension (2015 Edition), Expert Consensus on 3D Visualization Diagnosis and Treatment of Gallbladder Cancer (2018 Edition) and Expert Consensus on 3D Visualization Diagnosis and Treatment of Iatrogenic Bile Duct Injury (2018 Edition).He has published more than 30 papers as the first author or corresponding author, including 6 papers included in SCI, and participated in the preparation (translation) of professional works such as "Hepatoportal Hypertension Surgery", "SAGES Hernia Surgery Manual", and so on. As the person in charge, he has won four projects including the National Natural Science Foundation of China and the three-year action plan to promote clinical skills and clinical innovation in municipal hospitals. As a key personnel, he participated in the "Research on the Pathogenesis and Treatment of Liver Cirrhosis and Portal Hypertension" and won the second prize certificate of Shanghai Medical Science and Technology Progress Award in 2007.
